Brokers Recommendations on: Palatin Technologies Inc. (NYSEMKT:PTN)

Palatin Technologies Inc. (NYSEMKT:PTN) belonging to the Medical sector which declined -3.43% and closed its last trading session at $0.61.

The company reported its last EPS on 6/30/2016 and is expected to report its next EPS on 11/10/2016. Currently, the stock has a 1 Year Price Target of $4.67.

The consensus recommendation, according to Zacks Investment research, is 1. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell. The Stock had a 1 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 1 and 1 respectively.

Palatin Technologies Inc. on 6/30/2016 reported its EPS as $-0.08 with the analysts projecting the EPS of the stock as $-0.06. The company beat the analyst EPS Estimate with the difference of $-0.02. This shows a surprise factor of -33.3%.

Many analysts have provided their estimated foresights on Palatin Technologies Inc. Earnings, with 2 analysts believing the company would generate an Average Estimate of $-0.09. Whereas they predicted High and Low Earnings Estimate as $-0.08 and $-0.09 respectively. While in the same Quarter Previous year, the Actual EPS was $-0.08.

The Company got Initiated by Noble Financial on 23-May-12 to Buy.

Insider Trades for Palatin Technologies Inc. show that the latest trade was made on 6 Sep 2016 where Wills (Stephen T), the Chief Operating Officer completed a transaction type “Buy” in which 268000 shares were traded at a price of $0.

Over the period of 6 months, Insider Purchases show a total of 1 transaction in which 10000 shares were traded.

3 analysts projected Price Targets for Palatin Technologies Inc. The analysts believe that the company stock price could grow as high as $6. The Low Price target projection by analysts is $4 and the Mean Price Target is $4.67.

Palatin Technologies Inc. (NYSEMKT:PTN) has the market capitalization of $48.09 Million. The company rocked its 52-Week High of $0.9 on Oct 19, 2015 and touched its 52-Week Low of $0.36 on Mar 17, 2016. The stock has Return on Assets (ROA) of -170.9 percent. Return on Equity (ROE) stands at 0% and Return on Investment (ROI) of 0 percent.

The stock is currently showing YTD performance of -8.52 Percent. The company has Beta Value of 1.66 and ATR value of 0.05. The Weekly and Monthly Volatility stands at 8.68% and 9.80%.

Company profile:

Palatin Technologies, Inc is a development-stage medical technology company involved in developing and commercializing products and technologies for diagnostic imaging, cancer therapy and ethical drug development These developments are based on its proprietary monoclonal antibody radiolabeling and enabling peptide platform technologies.